Roman Fazylov, PharmD, BCPS

Dr. Fazylov practices Internal Medicine at Kingsbrook Jewish Medical Center where he currently provides pharmacotherapy services to approximately 40 inpatient beds. He is board certified as a pharmacotherapy specialist and is a member of the American College of Clinical Pharmacy. 

Clinical Specialty

• Internal Medicine

Education

• PharmD, Arnold and Marie Schwartz College of Pharmacy, New York; 2014

Residencies:

• Post-Graduate Year 1(PGY1) Pharmacy Practice at Kingsbrook Jewish Medical Center
• Post-Graduate Year 2 (PGY2) Internal Medicine at Kingsbrook Jewish Medical Center

Honors and Awards

• 2016, Kingsbrook Jewish Medical Center Award: Excellence in Patient Physical Assessment
• 2015, Kingsbrook Jewish Medical Center Award: Excellence in Drug-Induced Diseases
• 2015, Kingsbrook Jewish Medical Center Award: Excellence in Pharmacotherapy
• 2015, Kingsbrook Jewish Medical Center Award: Excellence in Pharmacotherapy Research
• 2015, Kingsbrook Jewish Medical Center Research Recognition Award: 1^st Place in Clinical Research
• 2015, GNYHA &NYSCHP Antimicrobial Stewardship Achievement Certificate
• 2014, Merck Award for Outstanding Achievement in Pharmacology & Medicinal Chemistry

Research

• Combination antibiotics for multi-drug resistant bacteria
• Patient tailored empiric therapy for HCAP: moving away from the HCAP model
• Anticoagulant use in obesity
• Antibiotic pharmacokinetics and therapeutic drug monitoring

Recent Publications

• Methylnaltrexone versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit. Critical Care Medicine 42.12 (2014): A1512.
• Evaluation of a Novel Treatment Algorithm for Health Care Associated Pneumonia to Reduce the Use of Broad Spectrum Antibiotics, a Prospective Cohort Study. Fazylov, R, Peyko, V. Infect Dis Clin Pract 2017;25: 82-87
• Case Report: Heparin Overdose. Fletcher, R., Wassner, C., Fazylov, R., & Cohen, H. Critical Care Medicine 42.12 (2016): A1512.
• What is the Appropriate Duration of High Dose Atorvastatin Post Acute Coronary Syndrome. J Pharm Pract. 2015 Dec;28(6):555-60.

Recent Presentations

• New Drug Update: Exparel (Liposomal Bupivacaine), June 2016 Presented at the NYSCHP annual banquet
• Dosing Strategies for Antibiotics in Obese and Renally Impaired Populations March 2016 Presented to clinical staff at Kingsbrook Jewish Medical Center
• Medication Use Evaluation of Kcentra® in a Community Hospital Setting, February 2016 Presented at P&T committee meeting at Kingsbrook Jewish Medical Center                       
• Monoclonal Antibodies: A Pharmacological Review, January 2016 Presented at NYSCHP Jan Keltz Winter CE Program in Lake Placid, NY
• Empagliflozin, Cardiac Outcomes and Mortality, November 2015 Presented to clinical staff at Kingsbrook Jewish Medical Center
• Herbal Medicines, October 2015 Presented to first year Pharm.D. Candidates at Touro College of Pharmacy
• Aspirin for Prevention of Thromboembolism in Orthopedic Surgery Patients, August 2015 Presented to clinical staff at Kingsbrook Jewish Medical Center
• Critical Analysis of Warfarin Use in Rutland Nursing Home, August 2015 Presented at P&T committee meeting in Rutland Nursing Home
• Antibiotic Strategies in Community Acquired Pneumonia- Atypical Coverage, June 2015 Presented to the clinical staff at Kingsbrook Jewish Medical Center
• Evaluation of Novel Treatment Algorithm to Determine Effective Empiric Regimens for Health-care Associated Pneumonia, May 2015 Presented to pharmacy residents and preceptors at NYSCHP annual assembly &Eastern States conference
• 13 Valent Conjugated Pneumococcal Vaccine in the Geriatric Population, February 2015 Presented to the clinical staff at Kingsbrook Jewish Medical Center
• Therapeutic Hypothermia Post Cardiac Arrest: 33ºC vs. 36ºC, January 2015 Presented to clinical staff at Kingsbrook Jewish Medical Center
• The Role of Steroids in Septic Shock, November 2014 Presented to clinical staff at Kingsbrook Jewish Medical Center
• Patient Case: Acute Ischemic Stroke, September 2014 Presented to clinical staff at Kingsbrook Jewish Medical Center
• Growing Resistance in Gram Negative Infections, October 2014 Presented to clinical staff at Kingsbrook Jewish Medical Center
• Drug Induced Thrombocytopenia, September 2014 Presented to clinical staff at Kingsbrook Jewish Medical Center
• Patient Case: Osteosarcoma Pathophysiology and Emerging Treatment Modalities, March 2014 Presented to clinical staff NYU Langone Medical Center
• Immune Reconstitution Inflammatory Syndrom,  February 2014 Presented to clinical staff NYU Langone Medical Center
• Treatment Considerations in Rapid Sequence Intubation, November 2013 Presented to clinical staff NYU Langone Medical Center
• Anticonvulsants for the Treatment of Alcohol Withdrawal, November 2013 Presented to faculty and staff at the International Drug Information Center of Long Island University
• Intensive vs. Moderate Lipid Lowering Therapy after Acute Coronary Syndrome, October 2013 Presented to faculty and staff at the International Drug Information Center of Long Island University.
• New Drug Update: Canagliflozin, September 2013 Presented to faculty and staff at the International Drug Information Center of Long Island University.
• Central Congenital Hypoventilation Syndrome, June 2013 Presented to the clinical staff of neonatal ICU at Roosevelt Hospital
• Novel and Evolving Therapies for Seizures in Neonates, June 2013 Presented to the clinical staff of neonatal ICU at Roosevelt Hospital                             
• Formulary addition of glipizide, June 2013 Presented to the P&T committee at Roosevelt Hospital. 

Teaching Responsibilities

• PHRN 635 Clinical Pharmacokinetics
• SBAN 560 Cultural Competency
• PHPN 581 Pharmacotherapy 

Hobbies

Motorsports, cycling, hiking, and camping